Molibresib

Scientific Overview: Pan-BET bromodomain inhibitor; NUT carcinoma focus where BRD4-NUT fusion is oncogenic. BRD4-NUT fusion — rare but highly BET-dependent

Mechanism of Action: Pan-BET Inhibitor

Purity: ≥99%  |  Molecular Formula: C21H23FN4O4S

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.